4 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Treating Mucosal Candidiasis ... Note: Systemic antifungals ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
Overview of antifungal ... , and photoxic skin ... Coccidioidomycosis #coccidioides ... #valleyfever #management ... comparison #table #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... , and photoxic skin ... Coccidioidomycosis #pharmacology ... #management #treatment ... #coccidioides
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
involvement of skin ... therapy #HHV8 #KaposiSarcoma ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology